MindMap Gallery Abbott Laboratories Company History
This timeline chronicles the remarkable journey of Abbott Laboratories, a leader in healthcare innovation since 1888. Abbott was founded in 1888 by Dr. Wallace Abbott as the Abbott Alkaloidal Company, producing alkaloid-based medicines. The company expanded product lines in the early 1900s (tablets, liquid medicines, vitamins). During WWII (1940s), Abbott produced penicillin, blood volume expanders, and intravenous solutions. Postwar growth came through R&D advancements: antibiotics, anesthetics (Penthrane), diagnostics (blood glucose meters, hepatitis tests), and medical nutrition (Similac, Ensure). The company diversified into cardiovascular devices (stents), diabetes care (glucose meters), and molecular diagnostics (HIV, hepatitis tests). Significant restructuring in 2013 created AbbVie, a separate biopharmaceutical company focused on immunology (Humira) and oncology. Abbott retained diagnostics (laboratory systems, rapid tests), medical devices (diabetes: FreeStyle Libre, LibreSense; cardiovascular: stents, heart valves), nutrition (Ensure, Similac, Pedialyte), and established pharmaceuticals (generic medicines, branded generics). Strategic acquisitions: Alere (2017, rapid diagnostics), St. Jude Medical (2017, cardiovascular devices), CFR Pharmaceuticals (2014, emerging markets). Innovations in diabetes care: FreeStyle Libre (continuous glucose monitor, no fingersticks). Pandemic response: rapid COVID-19 tests (antigen, molecular, lab-based). Abbott continues to enhance global health through diagnostics, devices, nutrition, and generics.
Edited at 2026-03-25 15:05:13